← Leaderboards
Andrew John Norris
Bcn Biosciences, Llc
$2,202,078
Attributed
$4,064,740
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2008–25$2M$1.5M$1M$500K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,064,740 · 5
By mechanism
R44$3,026,290 · 1
R43$1,038,450 · 4
Top collaborators
- Subhrajit Saha5 shared
- Michael J Gresser1 shared
Others in their field
Top investigators on “Toxic Effect”
- George R Seage · Abt Associates, Inc.$224,114,540
- Peter C Adamson · National Childhood Cancer Foundation$126,756,857
- Gregory H Reaman · National Childhood Cancer Foundation$123,836,183
- Carol Nesel · Westat$116,355,411
- Mary M Horowitz · Medical College Of Wisconsin$90,165,506
- Barney Sparrow · Battelle Memorial Institute$88,494,220
Research focus
Toxic EffectPharmaceutical PreparationsFoundationsTissuesWhole-Body IrradiationIrradiationPlayAcuteRadiationRadiation ToxicityIonizing RadiationToxicologyRadiation InjuriesPublic Health RelevancePreventDoseAnimalsBiological SciencesNatural RegenerationNuclear AccidentsIntestinal EpitheliumIntestinesMalignant NeoplasmsMouse Model
Grant awards (8)
Mitigation of Radiation Induced Gastrointestinal Syndrome.$985,537
R44 · FY2025 · AI · contact PI
Mitigation of Radiation Induced Gastrointestinal Syndrome.$1,005,819
R44 · FY2024 · AI · contact PI
Mitigation of Radiation Induced Gastrointestinal Syndrome.$1,034,934
R44 · FY2023 · AI · contact PI
BCN057 as a mitigator of Radiation Induced Gastrointestinal Syndrome$299,668
R43 · FY2020 · AI · contact PI
BCN057 as a mitigator of Radiation Induced Gastrointestinal Syndrome$299,857
R43 · FY2019 · AI · contact PI
A dual acting drug for enhancing radiotherapeutic benefit$209,208
R43 · FY2014 · CA · contact PI
Botanical-derived drug discovery for cancer therapy$130,207
R43 · FY2008 · CA · contact PI
Translational research in a novel anti cancer agent$99,510
R43 · FY2008 · CA · contact PI